Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated

What Happens If I Stop My Daily Asthma Controller?

At a Glance

Stopping a daily asthma controller can allow airway inflammation to return before symptoms are obvious, leading to worsening control and a higher risk of an asthma attack. Do not stop on your own; a clinician may supervise a step-down to the lowest effective treatment.

Key Takeaways:

  • Do not stop or change your controller medication on your own.
  • Feeling fine usually means your medication is working, not that your asthma is cured [1].
  • Stopping your medication increases your risk of an asthma attack and loss of asthma control [1][2].
  • If your asthma has been well-controlled for a long time, or if you have concerns about cost or side effects, talk to your doctor. They may be able to safely lower your dose [3].

The Danger of Silent Inflammation

If you feel completely fine, it might seem logical to stop taking your daily asthma controller medication (such as inhaled corticosteroids). However, asthma is a chronic disease that causes inflammation in the airways of your lungs. This inflammation can be “silent”—meaning it is happening even on days when you are not coughing, wheezing, or feeling short of breath [4][5].

Daily controller medications work by reducing this background inflammation [4]. When you stop taking them, the inflammation gradually builds back up. Studies show that adults and children who stop their inhaled corticosteroids lose control of their asthma more quickly than those who continue their treatment [1][2]. This worsening can happen within weeks or months, and the inflammation can return before you even notice your symptoms are back [2][6].

Long-Term Risks: Airway Remodeling

The most immediate risk of stopping your medication is an asthma attack. However, over the long term, persistently uncontrolled inflammation may lead to structural changes in your lungs, a process called airway remodeling [7][8].

Airway remodeling can involve several changes to the breathing tubes:

  • Damage to the airway lining: The protective inner layer of the airways becomes injured [7].
  • Scarring (fibrosis): The tissues beneath the airway lining become thickened [7][9].
  • Muscle changes: The muscle surrounding the airways grows thicker, making the airways more prone to squeezing shut [7][8].
  • Increased mucus: The number of mucus-producing cells increases, leading to more congestion in the breathing tubes [7].

These changes are not guaranteed to happen to everyone who misses a dose, and the risk varies from person to person. However, if airway remodeling does occur, it can make the airways stiffer and less flexible, which may contribute to persistent breathing difficulties that do not fully improve with treatment [10][11][8]. Consistent use of your controller medication helps suppress the inflammation that drives these changes [4][12].

Can I Ever Stop My Inhaler?

You should never stop or taper your asthma medication without your doctor’s supervision. However, if your asthma has been well-controlled for a sustained period, your doctor might consider a “step-down” approach [3].

Stepping down usually means finding the lowest effective dose of your medication, rather than stopping it completely [3]. In some cases, depending on local guidelines and your specific condition, your doctor might switch you to a specific combination inhaler (like an inhaled corticosteroid mixed with formoterol) that you only use as-needed [13][14]. This is very different from using a standard quick-relief “rescue” inhaler (like albuterol) on its own. Using only a rescue inhaler without an anti-inflammatory controller can be dangerous and is linked to worse asthma outcomes [13][15].

What to Do If Symptoms Return

If you have stopped your medication or if you notice your symptoms worsening, follow your written asthma action plan and contact your prescriber. Seek immediate emergency medical care if you experience severe breathlessness, difficulty speaking or walking, blue or gray lips, or if your quick-relief rescue inhaler is not helping your symptoms.

Common questions in this guide

What may happen if I stop taking my daily asthma controller?
The airway inflammation caused by asthma can return even before you notice symptoms. Over weeks or months, asthma control may worsen and the risk of an asthma attack increases. Do not stop the medicine without speaking with your prescriber.
Does feeling well mean I no longer need my asthma controller?
Usually not. Feeling well often means the controller is keeping airway inflammation under control, rather than that asthma has gone away. Ask your clinician whether a supervised dose reduction is appropriate.
Can I safely lower or stop my asthma medicine?
Some people with well-controlled asthma can reduce treatment under medical supervision. A clinician usually aims for the lowest effective dose and may consider an as-needed inhaler that combines an anti-inflammatory medicine with formoterol. Do not taper or stop on your own.
Is using only a rescue inhaler enough if I stop my controller?
A quick-relief inhaler such as albuterol can ease symptoms, but it does not replace the anti-inflammatory protection of a controller when used alone. Relying only on a rescue inhaler can lead to worse asthma outcomes. Ask your clinician for a plan that controls both symptoms and inflammation.
What should I do if symptoms return after I stop my controller?
Follow your written asthma action plan and contact your prescriber promptly. Get emergency care for severe breathlessness, difficulty speaking or walking, blue or gray lips, or symptoms that do not improve with your quick-relief inhaler.
Can stopping my controller cause lasting changes in my airways?
Long-term, uncontrolled inflammation may contribute to airway remodeling, which can make the airways thicker and less flexible. This is not guaranteed after a missed dose, and risk varies from person to person. Taking the prescribed controller consistently helps reduce the inflammation that drives these changes.

Get notified when new evidence is published on asthma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Discontinuation of inhaled corticosteroids in patients with controlled asthma: The DISCO (Discontinuation of Inhaled Steroid in Controlled asthmatics Over 6 months) study.

    Kim JH, Jin J, Park SY, et al.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2021; (127(1)):123-130.e1 doi:10.1016/j.anai.2021.03.031.

    PMID: 33819615
  2. 2

    Exhaled nitric oxide predicts loss of asthma control in children after inhaled corticosteroids withdrawal.

    Chang DV, Teper A, Balinotti J, et al.

    Pediatric pulmonology 2019; (54(5)):537-543 doi:10.1002/ppul.24268.

    PMID: 30688035
  3. 3

    [IS INHALED CORTICOSTEROID STEP-DOWN RECOMMENDED FOR ADULT ASTHMA PATIENTS HAVE BEEN WELL CONTROLLED OVER THE LONG TERM WITH MODERATE OR HIGH-DOSE INHALED CORTICOSTEROIDS?]

    Okada N, Kabata H, Tanaka Y, et al.

    Arerugi = [Allergy] 2024; (73(2)):206-212 doi:10.15036/arerugi.73.206.

    PMID: 38522936
  4. 4

    The next frontier: From clinical remission to structural remission-rethinking airway remodeling in asthma.

    Kotsiou OS, Daniil Z

    Respiratory medicine 2026; (261()):109003 doi:10.1016/j.rmed.2026.109003.

    PMID: 42362118
  5. 5

    Airway structural involvement detected by quantitative computed tomography in controlled and uncontrolled asthma.

    Lima LP, Silva IME, Azevedo LB, et al.

    BMC pulmonary medicine 2026; (26(1)).

    PMID: 42387464
  6. 6

    Predictive risk factors for relapse after cessation of inhaled corticosteroids in well-controlled childhood asthma.

    Akturk H, Karakoc-Aydiner E, Ozen A, et al.

    Minerva pediatrica 2017; (69(4)):274-280 doi:10.23736/S0026-4946.16.04244-4.

    PMID: 26365745
  7. 7

    Bidirectional interaction of airway epithelial remodeling and inflammation in asthma.

    Banno A, Reddy AT, Lakshmi SP, Reddy RC

    Clinical science (London, England : 1979) 2020; (134(9)):1063-1079 doi:10.1042/CS20191309.

    PMID: 32369100
  8. 8

    Airway remodeling heterogeneity in asthma and its relationship to disease outcomes.

    Hsieh A, Assadinia N, Hackett TL

    Frontiers in physiology 2023; (14()):1113100 doi:10.3389/fphys.2023.1113100.

    PMID: 36744026
  9. 9

    Genes and Pathways Regulating Decline in Lung Function and Airway Remodeling in Asthma.

    Hur GY, Broide DH

    Allergy, asthma & immunology research 2019; (11(5)):604-621 doi:10.4168/aair.2019.11.5.604.

    PMID: 31332973
  10. 10

    Pathobiology of Airway Remodeling in Asthma: The Emerging Role of Integrins.

    Joseph C, Tatler AL

    Journal of asthma and allergy 2022; (15()):595-610 doi:10.2147/JAA.S267222.

    PMID: 35592385
  11. 11

    Heterogeneity of airway wall dimensions in humans: a critical determinant of lung function in asthmatics and nonasthmatics.

    Pascoe CD, Seow CY, Hackett TL, et al.

    American journal of physiology. Lung cellular and molecular physiology 2017; (312(3)):L425-L431 doi:10.1152/ajplung.00421.2016.

    PMID: 28062484
  12. 12

    Biologics and airway remodeling in asthma: early, late, and potential preventive effects.

    Varricchi G, Poto R, Lommatzsch M, et al.

    Allergy 2025; (80(2)):408-422 doi:10.1111/all.16382.

    PMID: 39520155
  13. 13

    Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update.

    Levy ML, Bacharier LB, Bateman E, et al.

    NPJ primary care respiratory medicine 2023; (33(1)):7 doi:10.1038/s41533-023-00330-1.

    PMID: 36754956
  14. 14

    [Novelties in the Treatment of Asthma].

    Leuppi JD, Bridevaux PO, Charbonnier F, et al.

    Revue medicale suisse 2022; (18(787)):1269-1274 doi:10.53738/REVMED.2022.18.787.1269.

    PMID: 35735152
  15. 15

    It is time to change the way we manage mild asthma: an update in GINA 2019.

    Muneswarao J, Hassali MA, Ibrahim B, et al.

    Respiratory research 2019; (20(1)):183 doi:10.1186/s12931-019-1159-y.

    PMID: 31412856

This page is for informational purposes only and does not constitute medical advice about stopping asthma controller medication. Do not change your treatment without speaking with your prescriber, and seek emergency care for severe breathing symptoms.